A randomized trial to evaluate lopinavir/ritonavir versus saquinavir/ritonavir in HIV-1-infected patients : the MaxCmin2 trial

Journal article

Peer reviewed

Ulrik B DRAGSTED, Jan GERSTOFT, Brian GAZZARD, Sharon WALMSLEY, Andrew HILL, Jens D LUNDGREN, Mike YOULE, Zoe FOX, Marcello LOSSO, Jorge BENETUCCI, …

Antiviral therapy, Vol.10(6), pp.735-743

2005

PMID: 16218173

Abstract

Antiviral agents

Immunopathology

Infectious diseases

Pharmacology. Drug treatments

Viral diseases

Viral diseases of the lymphoid tissue and the blood. Aids

Biological and medical sciences

Medical sciences

Human viral diseases

Immunodeficiencies. Immunoglobulinopathies

Immunodeficiencies

Antibiotics. Antiinfectious agents. Antiparasitic agents

6 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.66 HIV; 1.66.1372 Lipodystrophy
Web Of Science research areas: Infectious Diseases; Pharmacology & Pharmacy; Virology
ESI research areas: Pharmacology & Toxicology

This output has contributed to the advancement of the following goals:

Source: InCites

Title: A randomized trial to evaluate lopinavir/ritonavir versus saquinavir/ritonavir in HIV-1-infected patients : the MaxCmin2 trial
Creators: Ulrik B DRAGSTED - Hvidovre University Hospital, Copenhagen, Denmark
Jan GERSTOFT - Rigshospitalet, Copenhagen, Denmark
Brian GAZZARD - Chelsea and Westminster Healthcare Trust, London, United Kingdom
Sharon WALMSLEY - Toronto Hospital, University Health Network, Toronto, Canada
Andrew HILL - University of Liverpool, Liverpool, United Kingdom
Jens D LUNDGREN - Hvidovre University Hospital, Copenhagen, Denmark
Mike YOULE - Royal Free Hospital, London, United Kingdom
Zoe FOX - Hvidovre University Hospital, Copenhagen, Denmark
Marcello LOSSO - Hospital J.M. Ramos Mejia, Buenos Aires, Argentina
Jorge BENETUCCI - IUNDAI - Hospital F.J. Muniz, Buenos Aires, Argentina
Dushyantha T JAYAWEERA - University of Miami School of Medicine, Miami, United States
Armin RIEGER - University of Vienna Medical School - AKH, Vienna, Austria
Johan N BRUUN - Ullevål University Hospital, Oslo, Norway
Antonella CASTAGNA - Università Vita e salute, Ospedale San Rafaele, Milan, Italy
MaxCmin2 Trial Grp
Publication Details: Antiviral therapy, Vol.10(6), pp.735-743
Publisher: International Medical Press
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Infectious Diseases
Language: English
Resource Type: Journal article
PMID: 16218173
Record Identifier: 991031600149802976